Chirality in drug design

Pharmacochemistry Library

Volumn 28, Issue C, 1997, Pages 257-269

  Leysen, D ^a  

^a NV ORGANON   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957806571     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(97)80071-2     Document Type: Article

References (11)

1. Crossley R. Chirality and the biological activity of drugs (1995), CRC Press, Florida
2. May. Richards A. Scrip Magazine (1995) 20
3. April. Cavalla D. Scrip Magazine (1996) 13
4. Gaddumand J.H., and Picarelli Z.P. Brit. J. Pharmacol. 12 (1957) 323
5. Leysen J. In: Langer S.Z., Brunello N., Racagni C., and Mendlewics J. (Eds). Serotonin Receptor Subtypes : Pharmacological Significance and Clinical Implications (1992), Karger, Basel 34-35
6. Pazos A., Hoyer D., and Palacios J.N. Eur. J. Pharmacol. 106 (1984) 539
7. Macor J.E., Blake J., Fox C.B., Johnson C., Koe B.K., Lebel L.A., Morrone J.M., Ryan K., Schmidt A.W., Schulz D.W., and Zorn S.H. J. Med. Chem. 35 (1992) 4503
8. Stam N.J., Vanderheyden P., Kelder J., de Boer T., van Alebeek C., and Leysen D. Soc. Neuroscience 1159 (1994) 476.1
9. van der Burg W.J., Bonta I.L., Delobelle J., Ramon C., and Vargaftig B. J. Med. Chem. 1 (1970) 35
10. Nozulak J., Kalkman H.O., Floersheim P., Hoyer D., Schoeffter P., and Buerki H.R. J. Med. Chem. 38 (1995) 28
11. D. Leysen et al, to be published in J. Med. Chem.